Adrian Deitz

12/22/2022  /  10b5-1 Plans , Beneficial Owner , Board of Directors , Capital Markets , Corporate Counsel , Corporate Governance , Cybersecurity , Disclosure , Final Rules , Insider Trading , Investors , Pay-for-Performance , Publicly-Traded Companies , Regulatory Agenda , Risk Management , SEC Comment Letter Process , Securities and Exchange Commission (SEC) , Shareholder Proposals , Special Purpose Acquisition Companies (SPACs)

3/22/2022  /  10b5-1 Plans , Board of Directors , Confidential Information , Delaware General Corporation Law , Material Nonpublic Information , Publicly-Traded Companies , Regulation S-K , Reporting Requirements , Rule 10b-5 , Securities and Exchange Commission (SEC) , Securities Exchange Act , Stock Repurchases

4/10/2020  /  Board of Directors , Coronavirus/COVID-19 , Debt , Debt Repurchasing , Disclosure Requirements , Repurchase Options , Rule 10b-5 , Tender Offers

1/30/2020  /  Acquisitions , Administrative Procedure Act , Anti-Discrimination Policies , Anti-Harassment Policies , Anti-Kickback Statute , Antitrust Investigations , Appeals , Arbitration Awards , Attorney General , Backstop Agreements , BEPS , BitLicense , Blockchain , Board of Directors , Bonds , Capital Markets , CFIUS , CFTC , Chapter 11 , Claim Preclusion , Class Action , Commercial Bankruptcy , Common Stock , Congressional Investigations & Hearings , Congressional Subpoenas , Consumer Financial Protection Bureau (CFPB) , Cooperation Agreement , Copyright , Corporate Governance , Corporate Restructuring , Corporate Social Responsibility , Corporate Taxes , Corwin Doctrine , Covenant Lite Deals , Creditors , Cross-Border Transactions , DACA , DE Supreme Court , Debt Financing , Debtors , Department of Justice (DOJ) , Dischargeable Debts , Disgorgement , Disparate Impact , Dodd-Frank , Down Rounds , Drug Pricing , EBITDA , Employee Retirement Income Security Act (ERISA) , Employer Liability Issues , Employment Discrimination , Enforcement Actions , Enforcement of Foreign Judgments , Enterprise Act 2002 , Environmental Social & Governance (ESG) , EU , Fair Housing Act (FHA) , Federal Trade Commission (FTC) , FinTech , FIRRMA , Foreign Acquisitions , Foreign Investment , Foreign Issuers , FRCP 23 , General Data Protection Regulation (GDPR) , General Elections , GILTI tax , High-Yield Markets , Hong Kong , Hong Kong Stock Exchange , Individual Accountability , Initial Public Offering (IPO) , Intellectual Property Litigation , Intercreditor Agreements , International Arbitration , International Litigation , IRS , Issue Preclusion , Japan , Joint Venture , Legislative Agendas , Life Sciences , Listing Rules , Litigation Strategies , Make-Whole Premium , Mergers , MFW , Multinationals , National Security , PCAOB , Pharmaceutical Industry , Political Parties , Preferred Shares , Private Offerings , Privately Held Corporations , Proxy Advisory Firms , Publicly-Traded Companies , Refinancing , Regulatory Agenda , Reporting Requirements , SCOTUS , Securities and Exchange Commission (SEC) , Securities Litigation , Separation of Powers , Shareholder Activism , Shareholder Proposals , Shareholders , Split of Authority , State Labor Laws , Stock Drop Litigation , Tax Cuts and Jobs Act , Tax Litigation , Technology Sector , Third-Party Release Agrements , Transparency , UK , UK Brexit , Valuation , White Collar Crimes

8/3/2018  /  Amended Rules , Board of Directors , Corporate Issuers , Corporate Officers , Disclosure Requirements , Employee Stock Purchase Rights , Equity Compensation , Executive Compensation , Financial Statements , Form S-8 , Offerings , Private Offerings , Public Comment , Publicly-Traded Companies , Qualified Restricted Stock Units (RSUs) , Rule 701 , Securities and Exchange Commission (SEC) , Solicitation , Stock Options , Threshold Requirements

11/5/2015  /  Annual Reports , Board of Directors , Capital Raising , Corporate Officers , Crowdfunding , Exemptions , Funding Portal , JOBS Act , Proposed Amendments , Public Comment , Public Offerings , Registration Requirement , Regulation D , Residency Requirements , Rule 147 , Rule 501 , Rule 504 , Securities Act of 1933 , Securities and Exchange Commission (SEC) , Securities Exchange Act